Medicenna to Present at Healthcare Investor Conference

Medicenna Therapeutics Corp. is scheduled to present at the 2026 Bloom Burton & Co. Healthcare Investor Conference. This presentation offers the company an opportunity to showcase its latest developments and strategic initiatives to a key audience of healthcare investors. Participation in such conferences is crucial for biotechnology firms seeking to attract investment, build partnerships, and raise awareness about their therapeutic pipelines and research advancements.